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Moderating effect of IBS Acceptance on Psychosocial Mediators of Irritable Bowel 
Syndrome 
 
Abstract Background/Objective: In this study a theoretically driven model is presented 
of how gastrointestinal anxiety, behavioural response, symptom severity, quality of life and 
IBS acceptance interact to determine how people cope and respond in IBS. Method: Cross-
sectional data from 166 outpatients attending a motility disorders clinic was used to test a 
model of moderated serial mediation. Results: Gastrointestinal anxiety and behavioural 
response were found to serially mediate the relationship between symptom severity and 
quality of life; each step of this ‘indirect effect’ was significant at the p<.001 level. The 
strength of the mediatory effect was linearly related to IBS acceptance; a significant 
interaction was found between IBS acceptance as a moderator at the level of the indirect 
effect (-.0091, 95%CI = -.0163 to .0019). Conclusions: Findings suggest that the effect of 
multiple psychosocial variables in IBS experience and outcomes may be conditional on levels 
of IBS Acceptance. The theoretical and clinical implications of these findings are discussed.  
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Introduction   
 
Irritable Bowel Syndrome (IBS) is a functional bowel disorder (i.e. with no known 
physiological cause unlike Inflammatory Bowel Disease (IBD)) in which recurrent abdominal 
pain is associated with symptoms such as diarrhoea, constipation, urgency of defecation, 
bloating, or sensation of incomplete evacuation. Depending on stool patterns, IBS can be 
further specified as being diarrhoea predominant (IBS-D), constipation predominant (IBS-C), 
mixed or alternating type (IBS-M), or unspecified (IBS-U) (Lacy et al., 2016). IBS affects 
between 7.0-8.3% of the population of Europe (Sperber et al., 2017). Studies consistently find 
that those living with IBS experience a significantly reduced quality of life (Lacy et al., 
2016). Yet despite the conditions’ prevalence, well-documented clinical profile and 
associated economic burden (Drossman, 2016; Soubieres, Wilson, Poullis, Wilkins, & Rance, 
2015) the mechanisms through which people cope and respond in IBS remain poorly 
understood.  Drossman’s (2016) biopsychosocial model of IBS posits that early 
life/premorbid genetic and environmental factors (e.g. parenting, infection) might play a role 
in the development of both psychosocial (susceptibility to stress, psychological illness, 
psychological traits) and physiological (abnormal motility, visceral hypersensitivity) factors 
leading to the expression of IBS symptoms through an interplay between psychosocial and 
physiological factors via the interactions between Central Nervous System (CNS) and the 
Enteric Nervous System (ENS). 
 
Quality of Life   
Greater pain and discomfort are associated with poorer outcomes compared to more mild 
symptoms and symptom severity appears to be a strong predictor of the quality of life 
outcomes in IBS (De Gucht, 2015). Many with IBS report a loss of social or professional 
confidence relating to feelings of shame and embarrassment of their condition. Avoidance of 
intimacy, travel and leisure is also common, driven by fear of exacerbating symptoms 
(Schneider & Fletcher, 2008) as is a decrease in appetite and difficulty sleeping (Farzaneh, 
Bijan, Mehdi, Nosratollah, & Farbod, 2015; Kalani, Naliboff, Shih, Mayer, & Chang, 2017). 
Psychological distress is common amongst the IBS population and over 50% have a 
comorbid psychiatric diagnosis; depression, anxiety and somatisation being most frequently 
diagnosed (Creed et al., 2013). Evidence suggests that there is variance between IBS subtype 
(according to Rome III criteria: diarrhoea, constipation, mixed, or unspecified) and disease-
related quality of life, with poorer outcomes in domains of food avoidance, relationships and 
daily activity impact for IBS-diarrhoea and IBS-mixed subtypes (Singh et al., 2015). Several 
psychosocial variables have been linked with poor outcomes, shaping how people cope and 
respond to symptoms in IBS (Van Oudenhove et al., 2016).  
 
Gastrointestinal Anxiety    
Gastrointestinal anxiety is a typical characteristic of IBS experience and can be defined as 
“the cognitive, affective and behavioural response stemming from fear of gastrointestinal 
sensations and symptoms and the context in which [they] occur” (Labus, Mayer, Chang, 
Bolus, & Naliboff, 2007). Strongly associated with psychological well-being, overall quality 
of life and symptom severity and illness perception (Knowles et al., 2017), gastrointestinal 
anxiety has been hypothesised and demonstrated as a key mediator of the relation between 
IBS symptom severity and quality of life (Wolitzky-Taylor, Craske, Labus, Mayer, & 
Naliboff, 2012).  
 
Behavioural Response  
Impact on quality of life could also been, at least in part, to stereotyped maladaptive 
behavioural patterns commonly observed in IBS (Reme, Kennedy, Jones, Darnley, & 
Chalder, 2010). Often these patterns are related to specific abnormal illness behaviours such 
as somatization and excessive consultation (Van Oudenhove et al., 2016). By far the most 
common behavioural strategy employed in IBS is avoidance; to cope with visceral sensations 
which prompt unpleasant cognitions and emotions, situations which may provoke these 
negative experiences are typically avoided (Drossman et al., 2009). Such scenarios include 
social interaction, certain foods or meal times, leisure activities where a bathroom may not be 
accessible, exercise, sex or the workplace. As a behavioural strategy, the tactic of ‘limiting 
exposure’ is associated with a poorer quality of life. Rutter & Rutter (2002)have shown 
variants of avoidant behaviour such as behavioural disengagement and restraint coping, 
mediate poor psychological outcomes including anxiety and depression. Their work 
highlights the close association of belief and expectations about the IBS (illness 
representation) and maladaptive avoidant behaviours.  Indeed, these behaviours show 
persistence even in the absence of symptoms, suggesting a potentially stronger relation 
between illness representation and negative, stereotyped behavioural outcome than possibly 
expected (Corney & Stanton, 1990).  
 
IBS Acceptance    
Acceptance as a core construct of the Acceptance and Commitment Therapy framework 
(ACT; Hayes, Strosahl, & Wilson, 1999) can be defined as “a willing contact with negative 
private experiences (physical or psychological) in the service of living a more valued life” 
(ACT; Hayes, Strosahl, & Wilson, 1999). Ferreira et al. (2014) provide a useful 
conceptualization of the IBS experience from an ACT framework: “A proportion of IBS 
patients can be functionally characterized by the use of behaviours that seek to control, 
eliminate or alter the physical, emotional and cognitive experiences associated with IBS 
both in the presence or absence of symptoms. These behaviours seem to be motivated by an 
excessive fusion with a self-conceptualization of being an IBS patient; fusion with unhelpful 
illness specific beliefs or cognitions; and by a dominance of feared future consequences or 
comparison with an idealized past. IBS patients also tend to choose to engage in these 
avoidant behaviours that provide short-term relief from their experiences over engaging in 
behaviours that are values-consistent and that might lead to better life satisfaction on the 
long-term.”(p.33). Therefore, IBS acceptance could be seen as a form of willingness 
to come into contact with unpleasant experiences of physical symptoms and with the 
feelings of embarrassment, anticipatory anxiety and distressing thoughts commonly 
associated with IBS; whilst at the same time pursuing valued life activities regardless of the 
presence of IBS (Ferreira et al., 2014; Ferreira, Eugenicos, Morris, & Gillanders, 2013). 
Recent evidence from Ferreira, Gillanders, Morris, & Eugenicos (2018) found that as a 
process of change, increase in IBS acceptance is associated with improved quality of life 
outcomes, reduced avoidant behaviours and reduced gastrointestinal anxiety. A subsequent 
component study using self-help resources aimed to IBS acceptance replicated some of these 
outcomes, specifically reductions in gastrointestinal anxiety and symptom severity 
(Gillanders, Ferreira, Angioni, Carvalho, & Eugenicos, 2017).  
 
Rationale 
Multiple psychosocial variables are implicated in the relationship between symptom 
severity and quality of life in IBS. The aim of this study is to present and test a theoretically-
driven model which reconciles symptom severity, gastrointestinal anxiety, behavioural 
response, quality of life and IBS acceptance to explain how people cope and respond in IBS. 
Our two hypotheses below are summarised in a model of moderated serial mediation (Figure 
1).  
 
Hypothesis 1: The relationship between symptom severity on quality of life in IBS is serially 
mediated by gastrointestinal anxiety and subsequent behavioural response.  
 
Hypothesis 2: Levels of IBS acceptance moderate the mechanism through which 
gastrointestinal anxiety and behavioural response serially mediate the effect of symptom 
severity on quality of life.   




The study drew on secondary, cross-sectional data combined from participants recruited to 
take part in two ACT-based intervention studies conducted at the University of Edinburgh 
(Ferreira et al., 2018, N=121; Gillanders et al., 2017, N=45). Both studies recruited 
gastroenterology outpatients from a motility disorders clinic in Edinburgh, UK. 
Gastroenterology consultants confirmed all participants were on the IBS ‘refractory’ 
spectrum (having experienced no symptom improvement under primary care treatment for 
the past 12 months) using the Rome III criteria (classifying IBS-type as diarrhoea, 
constipated or mixed) (Lacy et al., 2016) and clinical interview. Participants were required to 
be fluent in English and over 18 years old. Pregnant, breast feeding or any participant with a 
cognitive impairment or symptoms of inflammatory or neoplastic disorder were excluded 
from the study.  
 
Data Sample  
The study utilised single time-point data collected before intervention including self-report 
measures of symptom severity, quality of life, gastrointestinal anxiety, behavioural response 
and IBS Acceptance. Demographic data collected from participants included age, marital 
status, educational level, ethnic origin, nationality and employment type. Consent was gained 
from all participants. The study was approved by the University of Edinburgh ethics board. 
 
Measures 
The Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) (Francis, Morris, & 
Whorwell, 1997) measures five components of IBS symptoms as reported by the patient. Pain 
severity, pain frequency, distension, bowel satisfaction, and general impact on quality of life 
are rated from 0-100. Each subscale employs a visual analogue scale, with a total score out of 
500. Patient scores are stratified according to case severity: mild (75-175), moderate (175-
300) and severe (300+). Control cases with no IBS score below 75. The IBS-SSS shows 
acceptable reliability, and good concurrent validity with quality of life outcomes (Coffin, 
Dapoigny, Cloarec, Comet, & Dyard, 2004). In the current study internal consistency was 
α=.70. 
 
The IBS36 (Groll et al., 2002) is a quality of life measure in IBS composed of 36-items. The 
measure comprehensively assesses aspects of life quality including sleep, food, social 
functioning, daily activity, sexual relations and emotional impact. Each item is scored by self-
report on a Likert scale of frequency from 1 (never) - 7 (always). Scores are totalled out of 
216 and higher scores indicate greater impact of IBS on quality of life. The IBS36 shows 
good internal consistency, construct validity, test-retest reliability and good responsiveness 
(Groll et al., 2002).  In the current study internal consistency was α=.95. 
 
The Visceral Sensitivity Index (VSI) (Labus et al., 2004) is a specific measure of GI-related 
anxiety in IBS. Made up of 15 items, each is scored on an agreement Likert scale from 1 
(Strongly Agree) to 5 (Strongly Disagree). The scale assesses fear-related psychological and 
behavioural responses to visceral symptoms and the context in which they arise. Higher 
scores convey greater GI-related anxiety.  The scale has good internal consistency, content 
and predictive validity (Labus et al., 2004; Labus et al., 2007). In the current study internal 
consistency was α=.92. 
 
The Irritable Bowel Syndrome Behavioural Response Questionnaire (IBS-BRQ) (Reme, 
Darnley, Kennedy, & Chalder, 2010) measures stereotyped maladaptive IBS behaviours. It 
contains 26 items, each rated by self-report on a 1-7 Likert scale from 1 (never) to 7 (always). 
Assessed behaviours include: control of symptoms, specific food avoidance or seeking, 
avoidance of socialising, avoidance of normal activity including work and plan making, 
hypervigilance and repeated reassurance need.  Higher scores reflect higher IBS-related 
behavioural patterns. In the current study internal consistency was α=.90. 
 
The Irritable Bowel Syndrome Acceptance and Action Questionnaire (IBSAAQ) (Ferreira, 
Eugenicos, Morris, & Gillanders, 2013) is a 19-item scale of IBS specific acceptance. The 
IBS-AAQ is comprised of two factors: IBS Willingness and Activity Engagement. These 
cover acceptance of IBS symptoms and their severity, general quality of life, gastrointestinal 
anxiety, avoidance coping behaviours and psychological distress. Scores out of 120 indicate 
IBS acceptance levels with higher scores indicating greater acceptance. The IBS-AAQ has 
good interval consistency and test-retest reliability (Ferreira et al., 2013). In the current study 
internal consistency was α=.81. 
 
Statistical Analysis   
All analyses were completed using SPSS, version 25. Association of demographic variables 
with all measures were calculated to check for potentially confounding sources of spurious 
association. Ordinary least squared (OLS) regression-based path analysis was employed to 
test our hypotheses. Unstandardized regression coefficients were estimated as recommended 
in Hayes (2018), quantifying each step of the hypothesised model. For statistical inference, 
bootstrapped 95% confidence intervals were constructed for each estimate (Hayes, 2018). 
Bootstrapping samples were set to 10,000 and those which straddled zero were considered 
insignificant. 
Moderated Serial Mediation We tested a model of moderated serial mediation, using the 
PROCESS v3 macro for SPSS, model 91 (Hayes, 2018). This model estimates i) the direct 
(symptom severity  quality of life) and ii) indirect (symptom severity  gastrointestinal 
anxiety  behavioural response  quality of life) pathways are also simultaneously tested 
and ii) the strength and direction of any interaction with the indirect pathway at different 
values of the moderator (mean, +1SD, -1SD). The latter is calculated as an index of 
moderated mediation.  
 
Results 
Sample description   
The combined data set (N=166) had a mean age of 48.5 (13.2 ± SD) years and a 1 to 7.3 ratio 
of males (13.7%) to females (86.3%). This female-majority sample reflect the gender balance 
of the IBS patients attending specialized or tertiary gastroenterology services (Frissora & 
Koch, 2005). Average duration of IBS symptoms since diagnosis was 8.7 years (8.3 ± SD) 
and the most common Rome III classification was mixed sub-type (49.8%) with roughly 
equal constipated (17.8%) and diarrhoea (18.1%) sub-types. A small number of participants 
were ‘unsubtyped’. A proportion of the sample were unable to work as a result of their IBS 
(7.2%). A majority of participants were white (77%) whilst 18% were Afro-Caribbean and 
6% Asian. Full descriptive statistics for sociodemographic variables are presented in 
Appendix 1, Table 1.   
 
Correlations  
Zero-order correlations found a significant positive relationship between each hypothesised 
mediator (gastrointestinal anxiety, r = .50, p< .01 and behavioural response, r = .52, p<.001 
and symptom severity). Strong positive correlations were also found between quality of life 
and gastrointestinal anxiety (r = .68, p<.001) and behavioural response (r =.81, p<.001). The 
latter could suggest multicollinearity. Scrutiny of the two measures found slight construct 
overlap in social functioning and eating behaviours. However, as this overlap is limited and 
only .001 above an acceptable threshold for multicollinearity effects (Field, 2013), the 
behavioural response variable was considered sufficiently independent to be included in the 
analysis. Furthermore, OLS regression-based path analysis methodologically ‘partializes out’ 
any mediator variance from other mediators preventing multicollinearity contamination 
between mediators (Hayes, 2018). Descriptive normality calculations of variable measure 
data are shown in Appendix 1, Table 2. Partial correlation, between gastrointestinal anxiety 
and behavioural response when controlling for symptom severity as a common cause was 
found (r = .625, p<.001). No statistically significant associations were found between any 
demographic variable and any of the variables in the hypothesised model (all p<.05); 
therefore, none needed to be included as covariates in the analysis and the degrees of freedom 
and subsequent power of the model was not hampered. 
 
Path Analysis  
A model of serial mediation (Table 1) confirmed the significance of the direct effect of 
symptom severity on quality of life (coefficient .1390, 95% CI = .0970 - .1809, t =6.544, 
p<.001). The indirect regression path via gastrointestinal anxiety and behavioural response 
finds each step in the hypothesised mediation significant at the level of p <.001. The rationale 
for testing the full model of moderated serial mediation is strengthened by these results. 
 
INSERT TABLE 1 AROUND HERE 
 
Moderated Serial Mediation   
A significant interaction was estimated between moderator IBS acceptance and the mediator 
chain (-.0091, 95% CI = -.0163 to -.0019). A model summary of all regression coefficients is 
shown in Table 1. The strength of the indirect effect was at its greatest when IBS acceptance 
is weakest, and the higher the IBS acceptance score, the stronger the indirect effect. At one 
standard deviation above the mean IBS acceptance score (73.56) the weakest mediation 
occurred (.0485, 95%CI = .0235 to .0782), at mean IBS acceptance (57.00) the mediation 
effect was larger (.0607, 95%CI = .0342 to .0931) and at one standard deviation below mean 
IBS acceptance (36.88) the mediation effect is highest (.0756, 95%CI = .0436 to .1175). The 
linear relation of the strength of the mediation pathway as a function of IBS acceptance is 
represented graphically in Figure 2. The slope gradient is calculated by the index of 
moderated mediation (-.0007, 95%CI = -.0015 to -.0002). 
 
INSERT FIGURE 2 AROUND HERE 
 
Discussion 
The present study aimed to investigate acceptance in IBS and the interaction between 
acceptance and other psychological factors previously established as mechanisms driving the 
IBS symptom experience. Our findings suggest we can retain our hypotheses and propose 
IBS acceptance as a determinant of the boundary conditions under which symptom severity 
impacts on quality of life in IBS. 
The full model of moderated serial mediation found IBS acceptance to significantly interact 
at the level of the mediator chain from symptom severity to quality of life (via 
gastrointestinal anxiety and behavioural response). This indicates firstly, that the strength of 
the mediatory pathway appeared to be conditional on levels of IBS acceptance; and secondly, 
that the less IBS acceptance the stronger the mediation and the more IBS acceptance, the 
weaker the mediation effect. Our findings point toward a linear relation between IBS 
acceptance and the mediation of gastrointestinal anxiety and behavioural response in IBS 
experience. Therefore, the role of IBS acceptance in the mediatory path of experiences from 
symptom severity to quality of life could be an essential component when trying to 
understand or intervene in IBS.   
The IBS acceptance literature is still in its infancy and therefore few studies have 
attempted to describe a model in which IBS acceptance as a variable is incorporated. There is 
a debate on whether acceptance acts as a moderator or mediator in chronic illness 
experiences. The literature seems to be divided on this issue. For example Hulme, Chilcot, & 
Smith (2018) found illness coherence and acceptance to mediate the impact between doctor-
patient relationships and quality of life in IBS. However, psychological flexibility (which 
includes acceptance as a main factor)  has also been proposed to moderate the relationship 
between somatization, illness anxiety and on quality of life in psychosomatic symptoms 
(Leonidou, Panayiotou, Bati, & Karekla, 2017).  
We propose that acceptance could have both a mediator and a moderator role 
depending on the level of analysis. Within the ACT framework, as a continuous context-
dependant range of processes, the construct of acceptance appears to conceptually fit the role 
of moderator over mediator if the analysis is set at a singular point in time. That is, as a 
relational variable, acceptance is focused on how one relates to his/her own experience, and 
theoretically it is not affected by the experience itself (therefore negating an essential 
condition for mediation; Hayes et al., 2006). One could only conceptualize acceptance as a 
mediator if the construct itself is being targeted for change (through an intervention, or 
longitudinally through life events that might shape learning around acceptance as a 
behaviour). Therefore, and being theoretically consistent, at a single point observation, one 
could only conceptualize acceptance as a learned relational responding style that can 
influence the person’s experiential sense of the world, i.e. a moderator. This is further 
emphasized by the central claim of ACT that symptoms need not change for outcomes to 
improve, but it is actually the way people relate to their symptoms that needs to change 
(Hayes et al., 2006). On this basis, if acceptance acted as mediator with symptom severity as 
the first causal step, the latter would have to fluctuate in order to observe the changes in 
acceptance necessary for improvement – running against the definition of the construct. 
Furthermore, as an extension to this point, mathematically in OLS regression-based path 
analysis moderators behave differently to mediators. Mediators are causally related to one 
another, whilst moderators remain independent. Acceptance, unlike gastrointestinal anxiety 
and behavioural response, is - in our model - relatively independent of any of the 
psychosocial variables included in the model as it is not condition specific. Thus, the role of 
acceptance as a moderator of the afore mentioned mediator path seems to better fit our 
understanding of acceptance and its potential role in IBS. For example, it seem plausible that 
an individual experiencing severe symptoms of IBS would experience anxiety about his/her 
condition; if the individual scores high on IBS acceptance, this will provide a buffer between 
physical/psychological/emotional experiences and behaviour response, allowing for a more 
adaptive behavioural reaction to the afore mentioned experiences; this would in turn open up 
the possibility for the individual to remain more connected with valued activities instead of 
activities geared towards the control/elimination of IBS experiences, hence experiencing a 
better quality of life. In other words, the more accepting the stance to the dynamics of the 
condition, the greater the separation between fearful and anxious cognitions and behaviours 
which deteriorate quality of life. By the same token an individual with low IBS acceptance 
would find unhelpful symptom-related cognitions direct behaviours towards avoidance of 
scenarios perceived to expose such oneself to mental and physical unwanted experiences. 
Focus is detracted from pursuing valued ends in favour of the haven on offer from avoidance. 
Quality of life is ultimately impaired by a sense of a life not lived to the fullest of its 
possibility. In this way, acceptance acts as a context-dependant, protective trait when high 
and a risk factor for poor outcomes when low.  
On the other hand, several studies with populations similar to IBS (e.g. chronic pain 
which is a core symptom of IBS) have shown that changes in acceptance of illness following 
Acceptance and Commitment Therapy interventions mediate improvement in several 
physical and mental health outcomes (e.g. Vowles, Witkiewitz, Sowden, & Ashworth, 2014; 
Wicksell, Olsson, & Hayes, 2010). Therefore, given that acceptance is a highly trainable 
behavioural construct through Acceptance and Commitment Therapy, it stands to reason that 
the development and use of this intervention in IBS would prove of great clinical benefit.  
Two preliminary studies focusing on ACT for IBS (Ferreira, Gillanders, Morris, & 
Eugenicos, 2018; Gillanders et al., 2017) do seem to suggest that changes in IBS acceptance 
are at the core of improvements in the quality of life of IBS patients. In fact treatment related 
changes in IBS specific avoidance behaviours and Gastrointestinal anxiety in Ferreira, 
Gillanders, Morris, & Eugenicos (2018) are both dependent on changes in IBS acceptance, 
which would fit with the proposed model of this paper. In Gillanders et al. (2017) only 
Gastrointestinal anxiety was shown to be affected by IBS acceptance, however this seemed to 
be constricted by the findings that only the IBS willingness component of acceptance was 
significantly changing. Given the findings on the present study and the two aforementioned 
studies, it is possible to tentatively infer that IBS acceptance is a key variable in promoting 
change in two of the most evidence based variables known to mediate the path between IBS 
symptoms and Quality of Life. Several dismantling studies point towards the importance of 
focusing on the exposure to symptoms (or symptom related contexts) as a way of reducing 
gastrointestinal anxiety over more cognitive techniques such as stress management (e.g. 
Craske et al., 2011; Ljótsson et al., 2011). In recent studies by Ljótsson and colleagues (e.g. 
Ljótsson et al. 2013; Hesser, Hedman-Lagerlöf, Andersson, Lindfors & Ljótsson, 2018) 
where a mindfulness and exposure (key targets of ACT interventions) enhanced CBT 
protocol was found to improve outcomes (symptoms and quality of life) through reductions 
in gastrointestinal anxiety and avoidance behaviours. These studies could be seen to be 
utilizing a proxy version of an ACT intervention. However, given the findings of this study 
one could infer that by targeting IBS acceptance, it is possible that ACT might enhance the 
potential for patients to expose themselves to IBS symptoms and reduce their gastrointestinal 
anxiety.  This enhanced exposure could also be linked to a more acceptable re-framing that 
ACT provides for exposure; i.e. that is done in the service of valued directions that are 
intimately connected to a sense of quality of life.  
 
Limitations  
The use of single time-point, cross sectional data has implications for the kinds of 
conclusions we can draw from the results of the present study. Without longitudinal data, 
operationalising our hypothesised mediators, inference on causal relations between serial 
mediators must be done with caution as the explanatory power of the model cannot be 
established. Control data from healthy participants would also be necessary to strengthen 
causal inference. It could be argued that finding moderating effects of psychological 
flexibility is the product of the cross-sectional study design: static nature of the data means a 
continuous variable lends itself better to being conceptualised as more ‘trait-like’ as there is 
no indication of any variation in differing contexts. However, returning to Hayes et al. 
(2006), psychological flexibility is conceptualised as dialogic with differing contextual 
environments. One could therefore hypothesize that the nature of acceptance is transactional 
rather than static, however, such assertions based on the findings of this study could only be 
classified as preliminary and tentative. Finally, unaccounted for variables could yet be 




To better understand the relation of multiple psychosocial variables has numerous advantages 
compared to studying them in isolation. Gaining a more comprehensive picture of these 
interacting factors will allow for better prediction of outcomes and more effective, 
individually-tailored treatments. The present study takes tentative steps toward reframing 
how we conceptualise psychological flexibility in IBS and adding weight to the rational for 
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